14

Apr2021

NACI Process For Incorporating Economic Evidence Into Federal Vaccine Recommendations Consultation

BACKGROUNDThe National Advisory Committee on Immunization (NACI) provides the Public Health Agency of Canada (PHAC) with ongoing and timely medical, scientific, and public health advice relating to immunization.Traditionally, NACI reviewed safety, efficacy, immunogenicity, effectiveness and burden of illness in making recommendations for vaccine programs. PHAC has now expanded ... Read More

29

Mar2021

CADTH Releases Pharmaceuticals Reviews Update – Issue 22

CADTH’s Pharmaceutical Reviews Updates are used to communicate new CADTH reimbursement review process updates to the public. PDCI has outlined below the key highlights from the most recent update. For more information, please consult the CADTH website.... Read More

15

Jan2021

PMPRB Proposes Amendments to New Guidelines: Requests Consultation from Stakeholders

On January 13th 2021, as a consequence of the new PMPRB coming-into-force date, PMPRB has invited stakeholders to comment on two proposed amendments to the New Guidelines.  The two amendments pertain to (A) the Definition of Gap Medicines and (B) Compliance Timelines with Maximum List ... Read More

15

Jan2021

Released: PMPRB11 Potential Sources for Foreign Prices

The PMPRB has released a list of potential sources for prices in the PMPRB 11 basket of reference countries. A non-exhaustive list of examples of potential foreign sources can be found here. Starting July 1, 2021, the Patented Medicines Regulations will require patentees to ... Read More

08

Jan2021

Welcome Piraveena Sabesan to PDCI Market Access

We’re pleased to introduce you to newest member of the PDCI team, Piraveena Sabesan, in her role as Associate, HTA and Health Economics! Piraveena holds a Master of Biotechnology (Biopharmaceuticals) from the University of ... Read More

08

Dec2020

PMPRB Webinar on Online Filing Tool (December 7, 2020) – Attachment Included

Today the PMPRB hosted a webinar for their new online filing tool which will be available to all patentees as of January 1st, 2021. The webinar revealed a new Form 4 (which will provide PMPRB with the National Market size estimation for new medicines) along with a walk through of the ... Read More

07

Dec2020

PDCI Market Access Joins McKesson Canada

A Message fromKaitlyn Proulx Managing Director, PDCI Market Access I am thrilled to be sharing the news of the recent acquisition of PDCI Market Access by McKesson Canada Corporation. Over the years, PDCI has continued to grow and thrive ... Read More

03

Dec2020

INESSS Announces the Establishment of a Waiting List for Scientific Evaluations

INESSS has announced the implementation of a waiting list for requests for scientific evaluation received by INESSS as of November 16, 2020. PDCI has outlined below the key highlights from the most recent newsletter. The Institut national d’excellence en santé et en services sociaux (INESSS) has reported a ... Read More

01

Dec2020

Save the Dates! PMPRB has Released Upcoming Webinar Dates on the New Guidelines

The PMPRB has released dates for two webinars in December. Information regarding the PMPRB guidelines and these webinars can be located here. The webinar topics, targeted towards patentees, are as follows: Online Filing Tool Date: Monday, December 7, 2020 Time: 1:30pm - 2:30 pm ... Read More

25

Nov2020

PDCI’s PMPRB Follow-Up Webinar Postponed

The PMPRB hosted a webinar on November 20, 2020 and have published the presented slides on their website. PDCI Market Access will be postponing its webinar initially dated for November 26, 2020. The new date will depend on outcome of the upcoming PMPRB ... Read More